Bivalirudin for Children Undergoing Heart Procedures
Pharmacokinetics of Bivalirudin for Pediatric Anticoagulation
- Age
- Up to 17
- Sex
- Any
- Study type
- Observational
- Participants needed
- 30 (estimated)
- Sponsor
- Boston Children's Hospital · Other
This trial is looking for children under 18 who need a specific blood thinner called bivalirudin during heart procedures. Participants will help researchers understand how this medication works in younger patients.
You may be able to join if
- I am a pediatric patient under 18 years old.
- I weigh more than 3 kg.
- I am scheduled for a heart procedure or support.
- I need to receive bivalirudin as part of my treatment.
You may not be able to join if
- I am 18 years old or older.
- I weigh less than 3 kg.
- I have end-stage renal failure needing dialysis.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThis study will measure plasma concentrations of bivalirudin in pediatric patients undergoing cardiac catheterization, cardiac surgical procedures utilizing cardiopulmonary bypass (CPB), or extracorporeal support with ECMO, ventricular support devices (VAD) or lung-assist devices (LAD). The aim is to understand the pharmacokinetics of bivalirudin in these settings.
Loading trial locations…